We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$93.9B
AUM Growth
+$6.07B
(+6.9%)
Cap. Flow
-$722M
Cap. Flow
% of AUM
-0.77%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
2,724
New
225
Increased
1,153
Reduced
856
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$224M |
| 2 |
Entergy
ETR
|
+$194M |
| 3 |
General Dynamics
GD
|
+$190M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$147M |
| 5 |
Alibaba
BABA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$291M |
| 2 |
Valero Energy
VLO
|
+$197M |
| 3 |
Wells Fargo
WFC
|
+$196M |
| 4 |
Apple
AAPL
|
+$193M |
| 5 |
Macy's
M
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.35% |
| 2 | Financials | 10.69% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 6.49% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPXX
926
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $15.8M | 0.02% |
+523,500
| New | +$10.6M |
|
927
Stryker
SYK
$128B
| $15.7M | 0.02% |
131,392
+31,802
| +32% | +$3.56M |
|
|
RSTI
928
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $15.6M | 0.02% |
489,007
+223,835
| +84% | +$7.15M |
|
|
GGP
929
DELISTED
GGP Inc.
GGP
| $15.6M | 0.02% |
523,406
+70,458
| +16% | +$1.99M |
|
930
PUT
Hartford Financial Services
HIG
$39.4B
| $15.6M | 0.02% |
351,400
+204,800
| +140% | +$9.14M |
|
931
CALL
3M
MMM
$92.8B
| $15.6M | 0.02% |
106,444
+41,621
| +64% | +$5.87M |
|
932
PUT
American Airlines Group
AAL
$10.8B
| $15.5M | 0.02% |
549,000
+240,000
| +78% | +$8.11M |
|
933
PUT
Fidelity National Information Services
FIS
$21.8B
| $15.4M | 0.02% |
209,600
+85,900
| +69% | +$6.04M |
|
|
SLCA
934
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $15.3M | 0.02% |
443,810
+154,840
| +54% | +$4.29M |
|
935
Ligand Pharmaceuticals
LGND
$6.22B
| $15.3M | 0.02% |
205,170
-211,636
| -51% | -$15.7M |
|
936
PUT
Exelon
EXC
$46.5B
| $15.2M | 0.02% |
587,298
+164,595
| +39% | +$4.07M |
|
|
PVTB
937
DELISTED
PrivateBancorp Inc
PVTB
| $15.2M | 0.02% |
345,804
-101,281
| -23% | -$4.13M |
|
938
PUT
Viatris
VTRS
$19.9B
| $15.2M | 0.02% |
352,100
+141,500
| +67% | +$6.26M |
|
939
CALL
Bristol-Myers Squibb
BMY
$130B
| $15.2M | 0.02% |
206,500
+112,100
| +119% | +$7.92M |
|
940
PUT
Archer Daniels Midland
ADM
$37.4B
| $15.2M | 0.02% |
354,100
+177,900
| +101% | +$7.09M |
|
|
ATVI
941
PUT
DELISTED
Activision Blizzard
ATVI
| $15.2M | 0.02% |
383,100
+301,600
| +370% | +$11.1M |
|
942
CALL
Amgen
AMGN
$218B
| $15.2M | 0.02% |
99,600
+71,000
| +248% | +$11M |
|
943
PUT
Prologis
PLD
$131B
| $15.2M | 0.02% |
309,000
+133,300
| +76% | +$6.26M |
|
944
PUT
Weyerhaeuser
WY
$18.3B
| $15.1M | 0.02% |
507,500
+342,600
| +208% | +$10.5M |
|
945
Sun Life Financial
SLF
$45.3B
| $15M | 0.02% |
458,421
+93,568
| +26% | +$3.14M |
|
946
Avista
AVA
$3.24B
| $14.9M | 0.02% |
333,514
-8,442
| -2% | -$346K |
|
|
RICE
947
DELISTED
Rice Energy Inc.
RICE
| $14.9M | 0.02% |
+675,000
| New | +$12.6M |
|
948
United Therapeutics
UTHR
$22.4B
| $14.9M | 0.02% |
140,295
-36,326
| -21% | -$4.05M |
|
949
PUT
Synchrony
SYF
$25.7B
| $14.9M | 0.02% |
587,500
+348,100
| +145% | +$10.1M |
|
950
CALL
Comcast
CMCSA
$88.8B
| $14.8M | 0.02% |
455,200
+284,000
| +166% | +$8.82M |
|
Similar funds
Allianz Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Allianz Asset Management held 2,724 positions worth $93.9B, up 6.9% from $87.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Allianz Asset Management's Q2 2016 filing shows 225 new, 1,153 increased, 856 reduced and 182 closed positions. Its largest new stake was S&P Global: 874,259 shares worth $93.8M. The largest sale was Teva Pharmaceuticals, an estimated $291M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- Allianz Asset Management's largest Q2 2016 buy was S&P Global: 874,259 shares worth $93.8M.
- Allianz Asset Management added most to Fluor in Q2 2016, an estimated $224M increase.
- Allianz Asset Management's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $291M.
- Allianz Asset Management fully exited ATMEL CORP in Q2 2016, selling an estimated $79.4M.
- Allianz Asset Management's ten largest holdings make up 10% of its $93.9B portfolio in Q2 2016.
- Allianz Asset Management opened 225 new positions and closed 182 in Q2 2016.
- Allianz Asset Management's portfolio value rose 6.9% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.